Biochemical aspects of the selective antiherpes activity of nucleoside analogues.
D000212:Acyclovir / Q000494:pharmacology; D000963:Antimetabolites; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003564:Cytidine Deaminase; D003844:DCMP Deaminase / Q000378:metabolism; D004279:DNA, Viral / Q000378:metabolism; D006564:Herpesviridae / Q000187:drug effects* / Q000201:enzymology; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D019384:Nucleic Acid Synthesis Inhibitors; D009700:Nucleoside Deaminases / Q000378:metabolism; D009703:Nucleoside-Phosphate Kinase / Q000378:metabolism; D009705:Nucleosides / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D011755:Pyrophosphatases / Q000378:metabolism; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D013937:Thymidine Kinase / Q000378:metabolism; D013939:Thymidine Phosphorylase / Q000378:metabolism; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
D000963:Antimetabolites; D000998:Antiviral Agents; D004279:DNA, Viral; D019384:Nucleic Acid Synthesis Inhibitors; D009705:Nucleosides; D012264:Ribonucleotide Reductases; D013940:Thymidylate Synthase; D013939:Thymidine Phosphorylase; D013937:Thymidine Kinase; D009703:Nucleoside-Phosphate Kinase; C020093:dTMP kinase; D009700:Nucleoside Deaminases; D003844:DCMP Deaminase; D003564:Cytidine Deaminase; C011530:deoxycytidine deaminase; D011755:Pyrophosphatases; C024909:deoxyribopyrimidine triphosphatase; D000212:Acyclovir